These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26868207)

  • 1. Extending FDA guidance to include consumer medication information (CMI) delivery on mobile devices.
    Sage A; Blalock SJ; Carpenter D
    Res Social Adm Pharm; 2017; 13(1):209-213. PubMed ID: 26868207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can You Diagnose Me Now? A Proposal to Modify FDA's Regulation of Smartphone Mobile Health Applications with a Pre-Market Notification and Application Database System.
    McInerney S
    Food Drug Law J; 2015; 70(1):161-85, ii. PubMed ID: 26292476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory frameworks for mobile medical applications.
    Censi F; Mattei E; Triventi M; Calcagnini G
    Expert Rev Med Devices; 2015 May; 12(3):273-8. PubMed ID: 25644202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta Testing a Novel Smartphone Application to Improve Medication Adherence.
    Sarzynski E; Decker B; Thul A; Weismantel D; Melaragni R; Cholakis E; Tewari M; Beckholt K; Zaroukian M; Kennedy AC; Given C
    Telemed J E Health; 2017 Apr; 23(4):339-348. PubMed ID: 27564971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of tailored consumer medicine information on patients with type 2 diabetes mellitus: A randomised controlled interventional study.
    Munsour EE; Awaisu A; Hassali MAA; Abdoun E; Dabbous Z; Zahran N; Ali H
    Int J Clin Pract; 2020 Aug; 74(8):e13527. PubMed ID: 32386077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Policy Considerations for Mobile Biosensors.
    Russell SM; de la Rica R
    ACS Sens; 2018 Jun; 3(6):1059-1068. PubMed ID: 29766721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consumer Medication Information: Similarities and Differences Between Three Canadian Pharmacies.
    Monkman H; Kushniruk AW
    Stud Health Technol Inform; 2017; 234():238-242. PubMed ID: 28186048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consumer understanding of prescription drug information: an illustration using an antidepressant medication.
    Shiffman S; Gerlach KK; Sembower MA; Rohay JM
    Ann Pharmacother; 2011 Apr; 45(4):452-8. PubMed ID: 21427296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suitability and readability of consumer medical information accompanying prescription medication samples.
    Wallace LS; Keenum AJ; Roskos SE; Blake GH; Colwell ST; Weiss BD
    Patient Educ Couns; 2008 Mar; 70(3):420-5. PubMed ID: 18178363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital Era of Mobile Communications and Smartphones: A Novel Analysis of Patient Comprehension of Cancer-Related Information Available Through Mobile Applications
    Kim C; Prabhu AV; Hansberry DR; Agarwal N; Heron DE; Beriwal S
    Cancer Invest; 2019; 37(3):127-133. PubMed ID: 30821518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Opportunity and Obstacles for Smartwatches and Wearable Sensors.
    Foster KR; Torous J
    IEEE Pulse; 2019; 10(1):22-25. PubMed ID: 30872210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All Consumer Medication Information Is Not Created Equal: Implications for Medication Safety.
    Monkman H; Kushniruk AW
    Stud Health Technol Inform; 2017; 234():233-237. PubMed ID: 28186047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Memory, Perceptions, and Preferences of Multimedia Consumer Medication Information: Experimental Performance and Self-Report Study.
    Monkman H; Kushniruk AW; Borycki EM; Sheets DJ; Barnett J
    JMIR Hum Factors; 2020 Dec; 7(4):e15913. PubMed ID: 33258780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing a Framework for Evaluating the Patient Engagement, Quality, and Safety of Mobile Health Applications.
    Singh K; Drouin K; Newmark LP; Rozenblum R; Lee J; Landman A; Pabo E; Klinger EV; Bates DW
    Issue Brief (Commonw Fund); 2016 Feb; 5():1-11. PubMed ID: 26934758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mobile Usability Testing in Healthcare: Methodological Approaches.
    Borycki EM; Monkman H; Griffith J; Kushniruk AW
    Stud Health Technol Inform; 2015; 216():338-42. PubMed ID: 26262067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Danish and Canadian Consumer Medication Information.
    Monkman H; Nøhr C; Kushniruk AW
    Stud Health Technol Inform; 2017; 241():147-152. PubMed ID: 28809198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warnings for drug-drug interactions in consumer medication information provided by community pharmacies.
    Panich J; Gooden A; Shirazi FM; Malone DC
    J Am Pharm Assoc (2003); 2019; 59(1):35-42. PubMed ID: 30416068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of postnatal depression smartphone applications available on application stores: an information quality analysis.
    Zhang MW; Ho RC; Loh A; Wing T; Wynne O; Chan SWC; Car J; Fung DSS
    BMJ Open; 2017 Nov; 7(11):e015655. PubMed ID: 29138195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Involvement as Experts in the Development and Assessment of a Smartphone App as a Patient Education Tool for the Management of Thalassemia and Iron Overload Syndromes.
    Ward R; Taha KM
    Hemoglobin; 2016 Sep; 40(5):323-329. PubMed ID: 27535692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.